BRCA1 and Inherited cancer-predisposing syndrome: Hereditary MTC is a different clinical context than other hereditary cancer syndromes (e.g., BRCA1, BRCA2), where penetrance is significantly lower, the genetic test can yield ambiguous results, and the effectiveness and perceived benefits of "treatment" is unknown or has significant side effects.